Nifedipine, a calcium channel blocker currently indicated for vasospastic and chronic stable
angina, undoubtedly will have many other uses because of its potent peripheral vasodilatory …

A comment on this article appears in" Nifedipine trials." Circulation. 1997 Mar 18; 95 (6):
1671-2. This is a comment on" Nifedipine and mortality. Grave defects in the dossier." …

Nifedipine, a calcium-channel blocker, differs in structure and mode of action not only from
the nitrates and beta blockers but also from the other well-known calcium-channel blockers …

Nifedipine was synthesized by Bayer Germany in 1966 and considered for clinical use as a
coronary vasodilator in patients with angina pectoris. Japanese investigators played a great …

Nifedipine is a calcium-channel blocking agent that has been effective for patients with
angina pectoris when used as single-agent therapy and as part of a combination regimen …

Nifedipine, a calcium channel blocker belonging to the dihydropyridine subclass, is widely
utilized in clinical practice for its antihypertensive and antianginal properties. This article …

Nifedipine 1 is an antagonist of calcium influx through the slow channel of the cell
membrane and has been shown to be an effective and relatively well-tolerated treatment for …

Nicardipine and nifedipine are structurally similar dihydropyridine calcium channel blockers
with demonstrated efficacy in the treatment of stable angina pectoris. The present study was …

Nifedipine is a dihydropyridine calcium channel antagonist with predominantly vasodilatory
activity. Modified-release formulations of nifedipine are effective antihypertensive and …